Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus

European Journal of Neuroscience

Volumn 14, Issue 10, 2001, Pages 1603-1612

  Müller, Marianne B ^a   Lucassen, Paul J ^b,e   Yassouridis, Alexander ^a   Hoogendijk, Witte J G ^c   Holsboer, Florian ^a   Swaab, Dick F ^d  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LEIDEN UNIVERSITY   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Depression; Glucocorticoids; Hippocampus; HPA system; Immunocytochemistry

Indexed keywords

EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; GROWTH ASSOCIATED PROTEIN; HEMATOXYLIN; SYNAPTOPHYSIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; BIPOLAR DISORDER; BRAIN SIZE; BRAIN TISSUE; CADAVER; CELL LOSS; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; COVARIANCE; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; NISSL STAINING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SILVER STAINING; TIME; TISSUE FIXATION;

ADULT; AGED; ANTIGENS; CELL DEATH; DEPRESSIVE DISORDER; FEMALE; GAP-43 PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GLUCOCORTICOIDS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROGLIA; PYRAMIDAL CELLS; SYNAPTOPHYSIN;

EID: 0035784124     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01784.x     Document Type: Article

References (49)

1. Axelson, D.A., Doraiswamy, P.M., McDonald, W.M., Boyko, O.B., Tupler, L.A., Patterson, L.J., Nemeroff, C.B., Ellinwood, E.H. & Krishan, K.R.R. (1993) Hypercortisolemia and hippocampal changes in depression. Psychiatry Res., 47, 163-173.
2. Bancher, C., Grundke-Iqbal, I., Iqbal, K., Fried, V.A., Smith, H.T. & Wisniewski, H.M. (1991) Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res., 539, 11-18.
3. Benowitz, L.I. & Routenberg, A. (1997) GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci., 20, 84-91.
4. Breitner, J.C. (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol. Aging, 17, 789-794.
5. Bremner, J.D., Narayan, M., Anderson, E.R., Staib, L.H., Miller, H.L. & Charney, D.S. (2000) Hippocampal volume reduction in major depression. Am. J. Psychiatry, 157, 115-117.
6. Calhoun, M.E., Jucker, M., Martin, L.J., Thinakaran, G., Price, D.L. & Mouton, P.R. (1996) Comparative evaluation of synaptophysin-based methods for quantification of synapses. J. Neurocytol., 25, 821-828.
7. Carroll, B.J. (1982) The dexamethasone suppression test for melancholia. Br. J. Psychiatry, 140, 292-304.
8. Coffey, C.E., Wilkinson, W.E., Weiner, R.D., Ritchie, J.C. & Aque, M. (1993) The dexamethasone suppression test and quantitative cerebral anatomy in depression. Biol. Psychiatry, 33, 442-449.
9. Eastwood, S.L., Burnet, P.W.J. & Harrison, P.J. (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience, 66, 309-319.
10. Heuser, I., Yassouridis, A. & Holsboer, F. (1994) The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J. Psychiatr. Res., 28, 341-356.
11. Holsboer, F. (1999) The rationale for the corticotropin-releasing hormome receptor antagonists to treat depression and anxiety. J. Psychiatr., Res., 33, 181-214.
12. Holsboer, F. & Barden, N. (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev., 17, 187-205.
13. Lagenstein, I., Willig, R.P. & Kuhne, D. (1979) Cranial computed tomography (CCT) findings in children treated with ACTH and dexamethasone: First results. Neuropädiatrie, 10, 370-384.
14. Lahtinen, H., Miettinen, R., Ylinen, A., Halonen, T. & Riekkinen, P.J. (1993) Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix. Brain Res. Bull., 31, 311-318.
15. Leverenz, J.B., Wilkinson, C.W., Wamble, M., Corbin, S., Grabber, J.E., Raskind, M.A. & Peskind, E.R. (1999) Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J. Neurosci., 19, 2356-2361.
16. Lorente de Nò, R. (1934) Studies on the structure of the cerebral cortex: Continuation of the study of the ammonic system. J. Psychol. Neurol., 46, 113-177.
17. Lucassen, P.J., Müller, M.B., Holsboer, F., Bauer, J., Holtrop, A., Wouda, J., Hoogendijk, W.J.G., de Kloet, E.R. & Swaab, D.F. (2001) Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am. J. Pathol., 158, 453-468.
18. Masliah, E., Fagan, A.M., Terry, R.D., DeTeresa, R., Mallory, M. & Gage, F.H. (1991a) Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp. Neurol., 113, 131-142.
19. Masliah, E., Terry, R.D., Alford, M., DeTeresa, R. & Hansen, L.A. (1991b) Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am. J. Pathol., 138, 235-246.
20. Mercken, M., Lubke, U., Vandermeeren, M., Gheuens, J. & Oestreicher, A.B. (1992) Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle. J. Neurobiol., 23, 309-321.
21. Müller, M.B., Toschi, N., Kresse, A.E., Post, A. & Keck, M.E. (2000) Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology, 23, 205-215.
22. Neve, R.L., Finch, E.A., Bird, E.D. & Benowitz, L.I. (1988) Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl Acad. Sci. USA, 85, 3638-3642.
23. Norenberg, M.D. (1994) Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol., 53, 213-220.
24. O'Brien, J.T., Ames, D., Schweitzer, I., Colman, P., Desmond, P. & Tress, B. (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br. J. Psychiatry, 168, 679-687.
25. Post, A., Holsboer, F. & Behl, C. (1998) Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-κB and neuroprotection by antioxidants. J. Neurosci., 15, 8236-8246.
26. Purba, J.S., Hoogendijk, W.J.G., Hofman, M.A. & Swaab, D.F. (1996) Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry, 53, 137-143.
27. Raadsheer, F.C., Hoogendijk, W.J.G., Stam, F.C., Tilders, F.J.H. & Swaab, D.F. (1994) Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology, 60, 436-444.
28. Raadsheer, F.C., van Heerikhuize, J.J., Lucassen, P.J., Hoogendijk, W.J.G., Tilders, F.J.H. & Swaab, D.F. (1995) Corticotropin-releasing hormone levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry, 152, 1372-1376.
29. Reul, J.M.H.M. & de Kloet, E.R. (1985) Two receptor systems for corticosterone in the rat brain: Microdistribution and differential occupation. Endocrinology, 117, 2505-2512.
30. Sachar, E.J. (1967) Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study. Arch. Gen. Psychiatry, 17, 554-567.
31. Sanchez, M., Young, L.J., Plotsky, P.M. & Insel, T.R. (2000) Distribution of corticosteroid receptors in the rhesus brain: Relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci., 20, 4657-4668.
32. Sapolsky, R.M., Krey, L.C. & McEwen, B.S. (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J. Neurosci., 5, 1222-1227.
33. Sapolsky, R.M., Krey, L.C. & McEwen, B.S. (1986) The neuroendocrinology of stress and aging: The glucocorticoid casade hypothesis. Endocrine Rev., 7, 284-301.
34. Sheline, Y.I., Wang, P.W., Gado, M.H., Csernansky, J.G. & Vannier, M.W. (1996) Hippocampal atrophy in recurrent major depression. Proc. Natl Acad. Sci. USA, 93, 3908-3913.
35. Starkman, M.N., Gebarski, S.S., Berent, S. & Schteingart, D.E. (1992) Hippocampal formation volume, memory dysfunction and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry, 32, 756-765.
36. Starkman, M.N., Giordani, B., Gebarski, S.S., Berent, S., Schork, M.A. & Schteingart, D.E. (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry, 46, 1595-1602.
37. Swaab, D.F., Grundke-Iqbal, I., Iqbal, K., Kremer, H.P.H., Ravid, R. & van de Nes, J.A.P. (1992) τ and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res., 590, 239-249.
38. Thiel, G. (1993) Synapsin I, synapsin II, and synaptophysin: Marker proteins of synaptic vesicles. Brain Pathol., 3, 87-95.
39. Ueda, K., Masliah, E., Saitoh, T., Bakalis, S.L., Scoble, H. & Kosik, K.S. (1990) Alz-50 recognizes a phosphorylated epitope of tau protein. J. Neurosci., 10, 3295-3304.
40. Uno, H., Lohmiller, L., Thieme, C., Kemnitz, J.W., Engle, M.J., Roecker, E.B. & Farrell, P.M. (1990) Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev. Brain Res., 53, 157-167.
41. Uno, H., Tarara, R., Else, J.G., Suleman, M.A. & Sapolsky, R.M. (1989) Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci., 9, 1705-1711.
42. Vakili, K., Pillay, S.S., Lafer, B., Fava, M., Renshaw, P.F., Bonello-Cintron, C.M. & Yurgelun-Todd, D.A. (2000) Hippocampal volume in primary unipolar major depression: A magnetic resonance imaging study. Biol. Psychiatry, 47, 1087-1090.
43. Van de Nes, J.A.P., Kamphorst, W., Ravid, R. & Swaab, D.F. (1993) Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain, 116, 103-115.
44. Vollmann-Honsdorf, G.K., Flügge, G. & Fuchs, E. (1997) Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus. Neurosci. Lett., 233, 121-124.
45. Wiedenmann, B. & Franke, W.W. (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell, 41, 1017-1028.
46. Wolf, H.K., Campos, M.G., Zentner, J., Hufnagel, A., Schramm, J., Elger, C.E. & Wiestler, O.D. (1993) Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J. Neuropathol. Exp Neurol., 52, 499-506.
47. Woolley, C.S., Gould, E. & McEwen, B.S. (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res., 531, 225-231.
48. Yao, G.L. & Kiyama, H. (1995) Dexamethasone enhances level of GAP-43 m-RNA after nerve injury and facilitates re-projection of the hypoglossal nerve. Mol. Brain Res., 32, 308-312.
49. Zwiers, H. & Coggins, P.J. (1990) Corticotropin (ACTH) inhibits the specific proteolysis of the neuronal phosphoprotein B-50/GAP-43. Peptides, 11, 951-954.